TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinoma

Woo-Kyun Bae1, Chang-Soo Hong1, Mi-Ra Park1

  • 1Department of Hemato-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea.

Cancer Letters
|December 10, 2017
PubMed

Insights

The tumor suppressor TAp73 inhibits colorectal cancer metastasis by upregulating KAI1 expression. This TAp73-KAI1 pathway is crucial for controlling cancer cell invasion and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • p73, a p53 family member, functions as a tumor suppressor involved in development and apoptosis.
  • The specific molecular mechanisms by which p73 inhibits cancer metastasis are not fully understood.

Purpose of the Study:

  • To elucidate the role of TAp73 in regulating colorectal cancer cell invasion, migration, and metastasis.
  • To identify the molecular targets and pathways involved in TAp73-mediated anti-metastatic effects.

Main Methods:

  • Investigated the effects of TAp73 induction and knockdown on colorectal cancer cell invasion and migration in vitro.
  • Identified KAI1 as a transcriptional target of TAp73 using molecular assays.
  • Assessed the impact of TAp73 and KAI1 on hepatic metastasis in vivo.
  • Analyzed TAp73 and KAI1 expression levels in primary and metastatic colorectal cancer tissues.

Main Results:

  • TAp73 induction reduced colorectal cancer cell invasion and migration; TAp73 knockdown increased these activities.
  • KAI1 expression was essential for TAp73's inhibitory effects on cell invasion and migration.
  • TAp73 induction elevated KAI1 expression and decreased hepatic metastasis in vivo.
  • TAp73 and KAI1 were overexpressed in primary colorectal cancers but downregulated in metastatic cancers, with a positive correlation between their expressions.

Conclusions:

  • TAp73 plays a novel role in suppressing colorectal cancer metastasis.
  • TAp73 exerts its anti-metastatic function by transcriptionally regulating KAI1.
  • The TAp73-KAI1 axis represents a potential therapeutic target for inhibiting colorectal cancer progression.